Search

Your search keyword '"Lonati, C."' showing total 354 results

Search Constraints

Start Over You searched for: Author "Lonati, C." Remove constraint Author: "Lonati, C."
354 results on '"Lonati, C."'

Search Results

1. Natural history of cN+ bladder cancer treated with radical cystectomy with or without perioperative treatment

2. Stage-specific recurrence rates post-radical cystectomy: A path to personalized oncological follow-up

3. Correction to: Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register (Internal and Emergency Medicine, (2023), 18, 4, (1049-1063), 10.1007/s11739-023-03254-3)

4. Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register

6. Quantification of Recirculation during Veno-Venous Extracorporeal Membrane Oxygenation: In Vitro Evaluation of a Thermodilution Technique

7. Alveolar Cytokines Profile and Physiological Mechanisms for Ventilator-induced Lung Injury to the Lung Excluded From Ventilation: An Experimental Study

8. Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin-deficient mice

9. Sexual outcomes in men who have sex with men who underwent radical prostatectomy

10. Treatment outcomes of men with stage 2 non-seminomatous germ cell tumours treated with primary retroperitoneal lymph node dissection: A systematic review

11. Perioperative complications after radical cystectomy for bladder cancer: an international multicenter collaboration

12. Oncologic surveillance for variant histology upper tract urothelial carcinoma

13. Implementing the follow-up schedule after radical nephrouretrectomy for low risk upper tract urothelial carcinoma

14. Independent predictors and patterns of early and late recurrence after radical cystectomy for bladder cancer: a multicenter collaboration

15. Oncologic surveillance intensity for variant histology versus pure urothelial carcinoma of the bladder after radical cystectomy

16. The multifaceted spectrum of liver cirrhosis in older hospitalised patients: Analysis of the REPOSI registry

17. Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry

18. Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry

19. Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register)

20. CHA₂DS₂-VASc score stratifies mortality risk in heart failure patients aged 75 years and older with and without atrial fibrillation [CHA(2)DS(2)-VASc score stratifies mortality risk in heart failure patients aged 75 years and older with and without atrial fibrillation]

21. Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register)

22. The multifaceted spectrum of liver cirrhosis in older hospitalised patients: Analysis of the REPOSI registry

23. Lung Biomolecular Profile and Function of Grafts from Donors after Cardiocirculatory Death with Prolonged Donor Warm Ischemia Time

25. Lung Protection by Hypercapnia Depends Critically on the Method Used to Raise CO2 in an Animal Model of Unilateral Pulmonary Artery Ligation

27. Antibiotic use and associated factors in a large sample of hospitalised older people

28. Diagnostic accuracy of preoperative lymph node staging of bladder cancer according to different lymph node locations: A multicenter cohort from the European Association of Urology – Young Academic Urologists

30. Treatment outcomes for men with stage 2 non-seminoma undergoing primary RetroPeritoneal Lymph Node Dissection (RPLND): A systematic review

31. Prediction of 90-day mortality after radical cystectomy for bladder cancer in large-scale multicenter collaboration study

32. The diagnostic issue of variant histologies in bladder cancer: Does the centre have an impact in detection accuracy?

33. Implementing the follow-up schedule after radical nephrouretrectomy for low risk upper tract urothelial carcinoma

34. Oncologic surveillance for variant histology upper tract urothelial carcinoma

36. P121 - Selecting the best candidates for cisplatin-based adjuvant chemotherapy after radical cystectomy in patients with pN+ bladder cancer

37. Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register

38. Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients

39. Mortality rate and risk factors for gastrointestinal bleeding in elderly patients

40. Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids

41. Validation of an easy questionnaire on the assessment of salt habit: the MINISAL-SIIA Study Program

42. Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register

43. Selecting the best candidates for cisplatin-based adjuvant chemotherapy after radical cystectomy in patients with pN+ bladder cancer

44. The role of prior bladder cancer on any recurrence and distant metastasis in patients treated with radical nephroureterectomy

45. Oncologic surveillance for variant histology bladder cancer after radical cystectomy

46. Diagnostic accuracy of preoperative lymph node staging of bladder cancer according to different lymph node locations: a multicentre cohort from the european association of urology – young academic urologists (EAU-YAU): urothelial carcinoma working group

47. Ureteral stenting does not increase the risk of metachronous upper tract urothelial carcinoma in patients with bladder cancer presenting with hydronephrosis in comparison with percutaneous nephrostomy: a multicenter analysis

48. Variant histology as predictor of upstaging at radical cystectomy for urothelial bladder cancer

49. Selecting the best candidates for cisplatin-based adjuvant chemotherapy after radical cystectomy in pN+ bladder cancer patients

50. Metastasis within three years from radical nephroureterectomy as a bridge to overall survival: implications for patient counseling, current, and future studies

Catalog

Books, media, physical & digital resources